tiprankstipranks
Valiant Organics Limited (IN:VALIANTORG)
:VALIANTORG
India Market

Valiant Organics Limited (VALIANTORG) AI Stock Analysis

Compare
1 Followers

Top Page

IN:VALIANTORG

Valiant Organics Limited

(VALIANTORG)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
₹240.00
▼(-14.29% Downside)
Action:ReiteratedDate:03/24/26
The score is held back primarily by weak financial performance (declining revenue, losses, and inconsistent cash flow) and a demanding valuation (high P/E). Technicals are mixed and provide only limited support, with short-term improvement but a still-negative longer-term trend.
Positive Factors
Balance sheet equity cushion
A reasonable equity ratio means shareholders' equity provides a durable capital cushion against cyclical downturns common in chemicals. This structural buffer supports working capital, credit access and capital spending over the next 2–6 months, improving resilience during recovery cycles.
Negative Factors
Declining revenue and profitability
A structural decline in revenue coupled with a swing to negative net income indicates weakened demand or competitive pressures. Persistent top-line deterioration undermines operating leverage, limits reinvestment capacity and raises risk of prolonged margin recovery over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet equity cushion
A reasonable equity ratio means shareholders' equity provides a durable capital cushion against cyclical downturns common in chemicals. This structural buffer supports working capital, credit access and capital spending over the next 2–6 months, improving resilience during recovery cycles.
Read all positive factors

Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)

Valiant Organics Limited Business Overview & Revenue Model

Company Description
Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chlorophenol; ortho chlorophenol; 2,4 di-chlorophenol; 2,4,6 tri- chlorophenol; 2,6 di-chlorophenol; and p...
How the Company Makes Money
null...

Valiant Organics Limited Financial Statement Overview

Summary
Overall fundamentals are weak: the income statement shows declining revenue and a swing to negative net income with negative EBIT/EBITDA margins. Cash flow is inconsistent and recently weaker, raising liquidity concerns. The balance sheet is comparatively better with a reasonable equity base, but leverage is significant and equity is trending down.
Income Statement
35
Negative
Balance Sheet
60
Neutral
Cash Flow
45
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue7.52B7.19B7.23B10.52B11.53B7.55B
Gross Profit2.67B2.62B470.01M1.81B2.17B2.19B
EBITDA895.07M615.51M425.75M1.77B2.12B2.11B
Net Income235.33M-37.36M-83.91M881.21M1.13B1.15B
Balance Sheet
Total Assets11.63B11.83B12.48B12.39B11.92B8.76B
Cash, Cash Equivalents and Short-Term Investments107.93M131.53M71.02M456.71M499.47M349.85M
Total Debt2.36B2.49B2.57B2.74B3.63B2.09B
Total Liabilities4.23B4.58B5.19B4.99B5.43B3.68B
Stockholders Equity7.40B7.25B7.29B6.89B6.13B5.02B
Cash Flow
Free Cash Flow797.52M256.03M90.70M862.19M-1.53B-562.54M
Operating Cash Flow922.42M564.32M840.00M2.38B-307.47M1.15B
Investing Cash Flow-702.45M-209.61M-649.88M-1.43B-1.24B-1.59B
Financing Cash Flow-230.76M-318.13M-231.19M-1.12B1.67B486.70M

Valiant Organics Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price280.00
Price Trends
50DMA
240.62
Negative
100DMA
257.33
Negative
200DMA
314.19
Negative
Market Momentum
MACD
-0.16
Negative
RSI
51.09
Neutral
STOCH
55.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Neutral. The current price of 280 is above the 20-day moving average (MA) of 226.54, above the 50-day MA of 240.62, and below the 200-day MA of 314.19, indicating a neutral trend. The MACD of -0.16 indicates Negative momentum. The RSI at 51.09 is Neutral, neither overbought nor oversold. The STOCH value of 55.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:VALIANTORG.

Valiant Organics Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
₹11.00B17.068.45%-14.27%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
₹5.02B-5.440.50%-3.11%-331.77%
49
Neutral
₹7.12B-10.640.39%
48
Neutral
₹8.67B-467.160.08%-28.32%93.44%
47
Neutral
₹6.65B52.5616.43%
46
Neutral
₹5.97B-2,425.331.07%-22.10%-85.56%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:VALIANTORG
Valiant Organics Limited
237.30
-26.60
-10.08%
IN:BHARATWIRE
Bharat Wire Ropes Ltd.
160.45
-19.95
-11.06%
IN:DECCANCE
Deccan Cements Ltd
619.25
-182.50
-22.76%
IN:EVERESTIND
Everest Industries Limited
316.75
-129.74
-29.06%
IN:FAIRCHEMOR
Fairchem Organics Ltd
473.80
-381.48
-44.60%
IN:HERANBA
Heranba Industries Limited
178.05
-32.05
-15.25%

Valiant Organics Limited Corporate Events

Valiant Organics Closes Trading Window Ahead of FY26 Results
Mar 26, 2026
Valiant Organics Limited has announced that its trading window for dealing in the company’s securities will be closed for directors, promoters, promoter group members, designated persons, their immediate relatives, and other connected person...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026